Literature DB >> 23911244

Surgical vein graft preparation promotes cellular dysfunction, oxidative stress, and intimal hyperplasia in human saphenous vein.

Michael J Osgood1, Kyle M Hocking2, Igor V Voskresensky2, Fan Dong Li3, Padmini Komalavilas4, Joyce Cheung-Flynn2, Colleen M Brophy4.   

Abstract

INTRODUCTION: Human saphenous vein (HSV) is the most widely used bypass conduit for peripheral and coronary vascular reconstructions. However, outcomes are limited by a high rate of intimal hyperplasia (IH). HSV undergoes a series of ex vivo surgical manipulations prior to implantation, including hydrostatic distension, marking, and warm ischemia in solution. We investigated the impact of surgical preparation on HSV cellular function and development of IH in organ culture. We hypothesized that oxidative stress is a mediator of HSV dysfunction.
METHODS: HSV was collected from patients undergoing vascular bypass before and after surgical preparation. Smooth muscle and endothelial function were measured using a muscle bath. Endothelial preservation was assessed with immunohistochemical staining. An organ culture model was used to investigate the influence of surgical preparation injury on the development of IH. Superoxide levels were measured using a high-performance liquid chromatography-based assay. The influence of oxidative stress on HSV physiologic responses was investigated by exposing HSV to hydrogen peroxide (H2O2).
RESULTS: Surgical vein graft preparation resulted in smooth muscle and endothelial dysfunction, endothelial denudation, diminished endothelial nitric oxide synthase staining, development of increased IH, and increased levels of reactive oxygen species. Experimental induction of oxidative stress in unmanipulated HSV by treatment with H2O2 promoted endothelial dysfunction. Duration of storage time in solution did not contribute to smooth muscle or endothelial dysfunction.
CONCLUSIONS: Surgical vein graft preparation causes dysfunction of the smooth muscle and endothelium, endothelial denudation, reduced endothelial nitric oxide synthase expression, and promotes IH in organ culture. Moreover, increased levels of reactive oxygen species are produced and may promote further vein graft dysfunction. These results argue for less injurious means of preparing HSV prior to autologous transplantation into the arterial circulation.
Copyright © 2014 Society for Vascular Surgery. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23911244      PMCID: PMC3926896          DOI: 10.1016/j.jvs.2013.06.004

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  30 in total

Review 1.  Oxidative stress and vein graft failure: a focus on NADH oxidase, nitric oxide and eicosanoids.

Authors:  Helen Weaver; Nilima Shukla; David Ellinsworth; Jamie Y Jeremy
Journal:  Curr Opin Pharmacol       Date:  2012-04-13       Impact factor: 5.547

2.  Purification and identification of secreted oxidative stress-induced factors from vascular smooth muscle cells.

Authors:  D F Liao; Z G Jin; A S Baas; G Daum; S P Gygi; R Aebersold; B C Berk
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

3.  A quantitative study of endothelial cell injury in aorto-coronary vein grafts.

Authors:  E Svendsen; H Dalen; J Moland; H Engedal
Journal:  J Cardiovasc Surg (Torino)       Date:  1986 Jan-Feb       Impact factor: 1.888

4.  Length-tension relationship of smooth muscle of the hog carotid artery.

Authors:  J T Herlihy; R A Murphy
Journal:  Circ Res       Date:  1973-09       Impact factor: 17.367

5.  Integrity of vein grafts as a function of initial intimal and medial preservation.

Authors:  F W LoGerfo; W C Quist; N L Cantelmo; C C Haudenschild
Journal:  Circulation       Date:  1983-09       Impact factor: 29.690

6.  A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.

Authors:  D M Stern; P P Nawroth; W Kisiel; D Handley; M Drillings; J Bartos
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

7.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.

Authors:  R F Furchgott; J V Zawadzki
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

Review 8.  Oxidative stress, nitric oxide, and vascular disease.

Authors:  Jamie Y Jeremy; Anthony P Yim; Song Wan; Gianni D Angelini
Journal:  J Card Surg       Date:  2002 Jul-Aug       Impact factor: 1.620

9.  Late failure in vein grafts: mediating factors in subendothelial fibromuscular hyperplasia.

Authors:  P E Karayannacos; J R Hostetler; M G Bond; G S Kakos; R A Williams; J W Kilman; J S Vasko
Journal:  Ann Surg       Date:  1978-02       Impact factor: 12.969

10.  Transduction of peptide analogs of the small heat shock-related protein HSP20 inhibits intimal hyperplasia.

Authors:  Deron J Tessier; Padmini Komalavilas; Bo Liu; Craig K Kent; Jeffrey S Thresher; Catherine M Dreiza; Alyssa Panitch; Lokesh Joshi; Elizabeth Furnish; William Stone; Richard Fowl; Colleen M Brophy
Journal:  J Vasc Surg       Date:  2004-07       Impact factor: 4.268

View more
  39 in total

1.  Surgical marking pen dye inhibits saphenous vein cell proliferation and migration in saphenous vein graft tissue.

Authors:  Shinsuke Kikuchi; Richard D Kenagy; Lu Gao; Thomas N Wight; Nobuyoshi Azuma; Michael Sobel; Alexander W Clowes
Journal:  J Vasc Surg       Date:  2015-04-30       Impact factor: 4.268

2.  Preservation solution impacts physiologic function and cellular viability of human saphenous vein graft.

Authors:  Eric S Wise; Kyle M Hocking; Susan Eagle; Tarek Absi; Padmini Komalavilas; Joyce Cheung-Flynn; Colleen M Brophy
Journal:  Surgery       Date:  2015-05-21       Impact factor: 3.982

3.  Pressure control during preparation of saphenous veins.

Authors:  Fan Dong Li; Susan Eagle; Colleen Brophy; Kyle M Hocking; Michael Osgood; Padmini Komalavilas; Joyce Cheung-Flynn
Journal:  JAMA Surg       Date:  2014-07       Impact factor: 14.766

4.  No-touch vein grafts and the destiny of venous revascularization in coronary artery bypass grafting-a 25th anniversary perspective.

Authors:  Ninos Samano; Michael Dashwood; Domingos Souza
Journal:  Ann Cardiothorac Surg       Date:  2018-09

5.  Short-term preoperative protein restriction attenuates vein graft disease via induction of cystathionine γ-lyase.

Authors:  Kaspar M Trocha; Peter Kip; Ming Tao; Michael R MacArthur; J Humberto Treviño-Villarreal; Alban Longchamp; Wendy Toussaint; Bart N Lambrecht; Margreet R de Vries; Paul H A Quax; James R Mitchell; C Keith Ozaki
Journal:  Cardiovasc Res       Date:  2020-02-01       Impact factor: 10.787

6.  Adenosine triphosphate as a molecular mediator of the vascular response to injury.

Authors:  Christy M Guth; Weifung Luo; Olukemi Jolayemi; Kalyan S Chadalavada; Padmini Komalavilas; Joyce Cheung-Flynn; Colleen M Brophy
Journal:  J Surg Res       Date:  2017-03-31       Impact factor: 2.192

7.  Brilliant blue FCF as an alternative dye for saphenous vein graft marking: effect on conduit function.

Authors:  Igor V Voskresensky; Eric S Wise; Kyle M Hocking; Fan Dong Li; Michael J Osgood; Padmini Komalavilas; Colleen Brophy; Joyce Cheung-Flynn
Journal:  JAMA Surg       Date:  2014-11       Impact factor: 14.766

Review 8.  Vein graft adaptation and fistula maturation in the arterial environment.

Authors:  Daniel Y Lu; Elizabeth Y Chen; Daniel J Wong; Kota Yamamoto; Clinton D Protack; Willis T Williams; Roland Assi; Michael R Hall; Nirvana Sadaghianloo; Alan Dardik
Journal:  J Surg Res       Date:  2014-01-30       Impact factor: 2.192

9.  P2X7R antagonism after subfailure overstretch injury of blood vessels reverses vasomotor dysfunction and prevents apoptosis.

Authors:  Weifeng Luo; Daniel Feldman; Reid McCallister; Colleen Brophy; Joyce Cheung-Flynn
Journal:  Purinergic Signal       Date:  2017-09-13       Impact factor: 3.765

Review 10.  Vein graft failure: from pathophysiology to clinical outcomes.

Authors:  Margreet R de Vries; Karin H Simons; J Wouter Jukema; Jerry Braun; Paul H A Quax
Journal:  Nat Rev Cardiol       Date:  2016-05-19       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.